Journal of Microbiology and Biotechnology

  • 제34권4호
  • /
  • Pages.804-811
  • /
  • 2024
  • /
  • 1017-7825(pISSN)
  • /
  • 1738-8872(eISSN)
한국미생물·생명공학회 (The Korean Society for Microbiology and Biotechnology)
권호 표지
DOI QR코드

DOI QR Code

Establishment of a Dual-Vector System for Gene Delivery Utilizing Prototype Foamy Virus

  • Soo-Yeon Cho (Department of Systems Biotechnology, Chung-Ang University) ;
  • Yoon Jae Lee (Department of Microbiology and Immunology, Jeju National University College of Medicine) ;
  • Seong-Mook Jung (Department of Systems Biotechnology, Chung-Ang University) ;
  • Young Min Son (Department of Systems Biotechnology, Chung-Ang University) ;
  • Cha-Gyun Shin (Department of Systems Biotechnology, Chung-Ang University) ;
  • Eui Tae Kim (Department of Microbiology and Immunology, Jeju National University College of Medicine) ;
  • Kyoung-Dong Kim (Department of Systems Biotechnology, Chung-Ang University)
  • 투고 : 2023.12.15
  • 심사 : 2024.02.06
  • 발행 : 2024.04.28
PDF 다운로드
⟨ 이전 논문 다음 논문 ⟩

초록

Foamy viruses (FVs) are generally recognized as non-pathogenic, often causing asymptomatic or mild symptoms in infections. Leveraging these unique characteristics, FV vectors hold significant promise for applications in gene therapy. This study introduces a novel platform technology using a pseudo-virus with single-round infectivity. In contrast to previous vector approaches, we developed a technique employing only two vectors, pcHFV lacking Env and pCMV-Env, to introduce the desired genes into target cells. Our investigation demonstrated the efficacy of the prototype foamy virus (PFV) dual-vector system in producing viruses and delivering transgenes into host cells. To optimize viral production, we incorporated the codon-optimized Env (optEnv) gene in pCMV-Env and the Woodchuck Hepatitis Virus Posttranscriptional Regulatory Element (WPRE) at the 3' end of the transgene in the transfer vector. Consequently, the use of optEnv led to a significant enhancement in transgene expression in host cells. Additionally, the WPRE exhibited an enhancing effect. Furthermore, the introduced EGFP transgene was present in host cells for a month. In an effort to expand transgene capacity, we further streamlined the viral vector, anticipating the delivery of approximately 4.3 kbp of genes through our PFV dual-vector system. This study underscores the potential of PFVs as an alternative to lentiviruses or other retroviruses in the realm of gene therapy.

키워드

과제정보

This research was supported by the Chung-Ang University Research Grants in 2022 and the Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI) funded by the Ministry of Health & Welfare, Republic of Korea (No. HI22C1510).

참고문헌

  1. Baum C, Dullmann J, Li Z, Fehse B, Meyer J, Williams DA, et al. 2003. Side effects of retroviral gene transfer into hematopoietic stem cells. Blood 101: 2099-2114. 
  2. Hidai C, Kitano H. 2018. Nonviral ggne therapy for cancer: a review. Diseases 6: 57. 
  3. Raper SE, Chirmule N, Lee FS, Wivel NA, Bagg A, Gao GP, et al. 2003. Fatal systemic inflammatory response syndrome in a ornithine transcarbamylase deficient patient following adenoviral gene transfer. Mol. Genet Metab. 80: 148-158. 
  4. Khan AS, Bodem J, Buseyne F, Gessain A, Johnson W, Kuhn JH, et al. 2019. Corrigendum to "Spumaretroviruses: updated taxonomy and nomenclature" [Virology 516 (2018) 158-164]. Virology 528: S0042-6822(18)30390-8. 
  5. Lindemann D, Rethwilm A. 2011. Foamy virus biology and its application for vector development. Viruses 3: 561-585. 
  6. Achong BG, Mansell PW, Epstein MA, Clifford P. 1971. An unusual virus in cultures from a human nasopharyngeal carcinoma. J. Natl. Cancer Inst. 46: 299-307. 
  7. Rethwilm A, Bodem J. 2013. Evolution of foamy viruses: the most ancient of all retroviruses. Viruses 5: 2349-2374. 
  8. Simantirakis E, Tsironis I, Vassilopoulos G. 2020. FV vectors as alternative gene vehicles for gene transfer in HSCs. Viruses 12: 332. 
  9. Trobridge GD, Miller DG, Jacobs MA, Allen JM, Kiem HP, Kaul R, et al. 2006. Foamy virus vector integration sites in normal human cells. Proc. Natl. Acad. Sci. USA 103: 1498-1503. 
  10. Lesbats P, Serrao E, Maskell DP, Pye VE, O'Reilly N, Lindemann D, et al. 2017. Structural basis for spumavirus GAG tethering to chromatin. Proc. Natl. Acad. Sci. USA 114: 5509-5514. 
  11. Nowrouzi A, Dittrich M, Klanke C, Heinkelein M, Rammling M, Dandekar T, et al. 2006. Genome-wide mapping of foamy virus vector integrations into a human cell line. J. Gen. Virol. 87: 1339-1347. 
  12. Hamann MV, Stanke N, Mullers E, Stirnnagel K, Hutter S, Artegiani B, et al. 2014. Efficient transient genetic manipulation in vitro and in vivo by prototype foamy virus-mediated nonviral RNA transfer. Mol. Ther. 22: 1460-1471. 
  13. King AMQ, Lefkowitz EJ, Mushegian AR, Adams MJ, Dutilh BE, Gorbalenya AE, et al. 2018. Changes to taxonomy and the international code of virus classification and nomenclature ratified by the international committee on taxonomy of viruses (2018). Arch. Virol. 163: 2601-2631. 
  14. Ledesma-Feliciano C, Hagen S, Troyer R, Zheng X, Musselman E, Slavkovic Lukic D, et al. 2018. Replacement of feline foamy virus bet by feline immunodeficiency virus vif yields replicative virus with novel vaccine candidate potential. Retrovirology 15: 38. 
  15. Hirata RK, Miller AD, Andrews RG, Russell DW. 1996. Transduction of hematopoietic cells by foamy virus vectors. Blood 88: 3654-3661. 
  16. Russell DW, Miller AD. 1996. Foamy virus vectors. J. Virol. 70: 217-222. 
  17. Vassilopoulos G, Trobridge G, Josephson NC, Russell DW. 2001. Gene transfer into murine hematopoietic stem cells with helper-free foamy virus vectors. Blood 98: 604-609. 
  18. Nasimuzzaman M, Persons DA. 2012. Cell Membrane-associated heparan sulfate is a receptor for prototype foamy virus in human, monkey, and rodent cells. Mol. Ther. 20: 1158-1166. 
  19. Plochmann K, Horn A, Gschmack E, Armbruster N, Krieg J, Wiktorowicz T, et al. 2012. Heparan sulfate is an attachment factor for foamy virus entry. J. Virol. 86: 10028-10035. 
  20. Zufferey R, Donello JE, Trono D, Hope TJ. 1999. Woodchuck hepatitis virus posttranscriptional regulatory element enhances expression of transgenes delivered by retroviral vectors. J. Virol. 73: 2886-2892. 
  21. Caprariello AV, Miller RH, Selkirk SM. 2009. Foamy virus as a gene transfer vector to the central nervous system. Gene Ther. 16: 448-452. 
  22. Burtner CR, Beard BC, Kennedy DR, Wohlfahrt ME, Adair JE, Trobridge GD, et al. 2014. Intravenous injection of a foamy virus vector to correct canine SCID-X1. Blood 123: 3578-3584. 
  23. Sweeney NP, Regan C, Liu J, Galleu A, Dazzi F, Lindemann D, et al. 2016. Rapid and efficient stable gene transfer to mesenchymal stromal cells using a modified foamy virus vector. Mol. Ther. 24: 1227-1236. 
  24. Trobridge GD. 2009. Foamy virus vectors for gene transfer. Expert Opin. Biol. Ther. 9: 1427-1436. 
  25. Trobridge GD, Russell DW. 1998. Helper-free foamy virus vectors. Hum. Gene Ther. 9: 2517-2525. 
  26. Kim DW, Uetsuki T, Kaziro Y, Yamaguchi N, Sugano S. 1990. Use of the human elongation factor 1 alpha promoter as a versatile and efficient expression system. Gene 91: 217-223. 
  27. Chittenden T, Frey A, Levine AJ. 1991. Regulated replication of an episomal simian virus 40 origin plasmid in COS7 cells. J. Virol. 65: 5944-5951.